A prospective study of dysgeusia and related symptoms in patients with multiple myeloma after autologous hematopoietic cell transplantation.
Michael ScordoGunjan L ShahPeter A AdintoriAndrea KnezevicSean M DevlinMarissa L BuchanElaina V PrestonAndrew P LinNatasia T RodriguezCaroline A CarinoLinh K NguyenNancy Cruz SitnerAndrei BaraschMark G KlangMolly A MaloyBrooke MastrogiacomoDean C CarlowRyan C SchofieldAnn E SlingerlandJohn B SlingerlandChristoph K Stein-ThoeringerOscar B LahoudHeather J LandauDavid J ChungMarcel R M van den BrinkJonathan U PeledSergio A GiraltPublished in: Cancer (2022)
Taste changes after cancer treatments are very common. We used chemical gustometry (taste testing) to study taste changes and to better understand why patients with multiple myeloma experience this symptom after autologous hematopoietic cell transplantation. We found that taste testing was feasible, taste changes peaked when blood counts were lowest, and most patients recovered their taste by 100 days after transplantation. Taste changes correlated with lower food intake and with higher levels of chemotherapy in the body. Future work will focus on using personalized chemotherapy doses to reduce taste changes and to match patients' individual taste preferences with their diets.